Google News

Bacteria in Your Mouth May Increase the Risk of Gut Diseases; Here's How You Can Keep Your Mouth Healthy! - NDTV


NDTV

Bacteria in Your Mouth May Increase the Risk of Gut Diseases; Here's How You Can Keep Your Mouth Healthy!
NDTV
Bacteria that normally live in our mouth may contribute to digestion problems or gut diseases that may include inflammatory diseases (IBD), Crohn's Disease and ulcerative colitis. According to the study published in the journal Science, when certain ...
Your Dirty Mouth Could Give You Digestion ProblemsGears Of Biz
Bacteria in your mouth could fuel gut diseasesPakistan Observer (blog)

all 4 news articles »Google News

Your Dirty Mouth Could Give You Digestion Problems - Newsweek


Newsweek

Your Dirty Mouth Could Give You Digestion Problems
Newsweek
MedicalXpress reports that a team of researchers realized their patients with bowel disorders (either irritable bowel syndrome, ulcerative colitis or Crohn's disease) had a lot of oral bacteria in their poop.Thinking the stomach must also have more of ...
Rise in Cases of Bowel Disease: 5 Diet Tips to Improve Your Bowel MovementsNDTV
Bowel disease to become more common in developing countries: ScientistsHindustan Times
Bowel disease to increase in developing countries: studyThe Indian Express
News-Medical.net
all 4 news articles »

Regulatory Recon: Celgene Abandons Late-Stage Trial in Crohn's Disease (20 October 2017) - Regulatory Focus


Regulatory Recon: Celgene Abandons Late-Stage Trial in Crohn's Disease (20 October 2017)
Regulatory Focus
So Is the Fix (Wall Street Journal-$); Statement by FDA Commissioner Scott Gottlieb, M.D. on medical device manufacturing recovery in Puerto Rico (FDA); What's Missing from FDA's Recent Approval Letter for Generic COPAXONE 40 mg/mL? (FDA Law Blog) ...

Celgene shares drop after Crohn's disease drug trials halted - MarketWatch


CNBC

Celgene shares drop after Crohn's disease drug trials halted
MarketWatch
Based on an analysis from a data monitoring committee assessing overall benefit and risk, Celgene said it would discontinue a late-stage clinical trial for the drug GED-0301 to treat Crohn's disease along with an extension trial. Crohn's disease is ...
Celgene to stop testing Crohn's drug, shares dropReuters
Celgene won't initiate phase 3 trial for Crohn's disease drugCNBC
UPDATED: Celgene's $710M deal on mongersen implodes as Phase III Crohn's study flopsEndpoints News
Nasdaq -Business Wire (press release) -Fox Business
all 16 news articles »

Research predicts increase in inflammatory bowel disease in developing world - EurekAlert (press release)


Research predicts increase in inflammatory bowel disease in developing world
EurekAlert (press release)
For the last century, inflammatory bowel disease (IBD) has been a challenge for patients and the medical community in the western world. New research published today in The Lancet by Dr. Gilaad Kaplan shows that countries outside the western world may ...

Pages